EcoDrugPlus

Ensembl ID : ENSOMYG00000021849
Gene Symbol: -
Cross references: -
320 Possible Orthologues:

Ensembl ID : ENSOMYG00000032616
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSOMYG00000032439
Gene Symbol: -
Cross references: -
249 Possible Orthologues:

Ensembl ID : ENSOMYG00000022329
Gene Symbol: -
Cross references: -
58 Possible Orthologues:

Ensembl ID : ENSOMYG00000032127
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSOMYG00000023286
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSOMYG00000023383
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSOMYG00000022939
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSOMYG00000032040
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSOMYG00000025094
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSOMYG00000025173
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSOMYG00000025458
Gene Symbol: -
1 Cross references
413 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).